ResearchInChina >> Listed Company >> Hualan Biological Engineering Inc.(002007.SZ)

Index>>Charts

Hualan Biological Engineering Inc.(002007.SZ)

Profile

Registered Capital:

576.20(RMB MLN)

Employees：

1282

Email：

hualan@hualanbio.com

WebSite：

http://www.hualanbio.com

Tel：

0373-3559989

Fax：

0373-3559991

News

Hualan Biological starts vaccine WHO pre-authentication

2012/4/23

Hualan Biological (002007.SZ): Second Flu Vaccine Workshop Passes New GMP Authentication

2011/10/17

Hualan Biological Engineering’s vaccine performance declined in 2011H1, blood product business expected to be favorable

2011/9/5

Hualan Bio H1 Earnings Down 30%

2011/8/17

Revenue Breakdown (million RMB)

Industry	2011H1	2010	2010H1	2009	2008	2007
Blood products	417.08	**	**	**	**	**
Vaccine products	52.76	**	**	**	**	**
Total	--	**	**	**	**	**

Products	2011H1	2010	2010H1	2009	2008	2007
Human serum albumin	**	**	**	**	**	**
Intravenous acrylic balls	**	**	**	**	**	**
Swine flu vaccine	**	**	**	**	**	**
Other vaccines	**	**	**	**	**	**
Other	**	**	**	**	**	**
Influenza vaccine	**	**	**	**	**	**
Total	**	**	**	**	**	**

Area	2011H1	2010	2010H1	2009	2008	2007
China North	65.59	**	**	**	**	**
East China area	159.78	**	**	**	**	**
South China area	82.71	**	**	**	**	**
Central China area	121.15	**	**	**	**	**
North West	40.61	**	**	**	**	**
In foreign countries	0.00	**	**	**	**	**
Total	469.84	**	**	**	**	**

Introduction from Company WebSite

Hualan Biological Engineering Inc. (her predecessor is Hualan Biological Engineering Ltd.), a nationally important hi-tech enterprise engaged in R&D and production of blood products, was founded in 1992. She became the first Chinese blood product manufacturer being granted GMP Certificate in 1998.

As a large-scale bio-pharmaceutical company, Hualan has occupied the top position in the industry in China based on great R&D strength, advanced technology, first-class test equipments, scientific management and integrated QA system. She successively and successfully completed several national, provincial and municipal technological tasks. Among them, Surgical Lyophilized Fibrin Sealant was listed in the national ‘863 Program' (High Tech Research And Development Program).